These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24966713)

  • 21. Using Ca
    Steele TWE; Eltit JM
    Psychopharmacology (Berl); 2019 Mar; 236(3):973-988. PubMed ID: 30448989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The psychoactive cathinone derivative pyrovalerone alters locomotor activity and decreases dopamine receptor expression in zebrafish (Danio rerio).
    Souders CL; Davis RH; Qing H; Liang X; Febo M; Martyniuk CJ
    Brain Behav; 2019 Nov; 9(11):e01420. PubMed ID: 31625691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
    Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?
    Ayres TC; Bond JW
    BMJ Open; 2012; 2(4):. PubMed ID: 22855623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.
    Spiller HA; Hays HL; Aleguas A
    CNS Drugs; 2013 Jul; 27(7):531-43. PubMed ID: 23757186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review.
    Alvarez JC; Fabresse N; Larabi IA
    Curr Pharm Des; 2017 Jan; 23(36):5487-5495. PubMed ID: 28677501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.
    Abbott R; Smith DE
    J Psychoactive Drugs; 2015; 47(5):368-71. PubMed ID: 26579784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
    Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
    Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic cathinones ("bath salts").
    Banks ML; Worst TJ; Rusyniak DE; Sprague JE
    J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical toxicology and management of intoxications with synthetic cathinones ("bath salts").
    Mas-Morey P; Visser MH; Winkelmolen L; Touw DJ
    J Pharm Pract; 2013 Aug; 26(4):353-7. PubMed ID: 23178412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives.
    Gatch MB; Dolan SB; Forster MJ
    J Pharmacol Exp Ther; 2015 Aug; 354(2):103-10. PubMed ID: 25998047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hazard Characterization of Synthetic Cathinones Using Viability, Monoamine Reuptake, and Neuronal Activity Assays.
    Zwartsen A; Olijhoek ME; Westerink RHS; Hondebrink L
    Front Neurosci; 2020; 14():9. PubMed ID: 32063828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective.
    Chen S; Zhou W; Lai M
    Brain Sci; 2024 Mar; 14(4):. PubMed ID: 38671986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
    Zawilska JB; Słomiak K; Wasiak M; Woźniak P; Massalski M; Krupa E; Wojcieszak JŁ
    Przegl Lek; 2013; 70(6):386-91. PubMed ID: 24052975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
    Bretteville-Jensen AL; Tuv SS; Bilgrei OR; Fjeld B; Bachs L
    Forensic Sci Rev; 2013 Mar; 25(1-2):7-26. PubMed ID: 26226848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Activity Relationship of Novel Second-Generation Synthetic Cathinones: Mechanism of Action, Locomotion, Reward, and Immediate-Early Genes.
    Nadal-Gratacós N; Alberto-Silva AS; Rodríguez-Soler M; Urquizu E; Espinosa-Velasco M; Jäntsch K; Holy M; Batllori X; Berzosa X; Pubill D; Camarasa J; Sitte HH; Escubedo E; López-Arnau R
    Front Pharmacol; 2021; 12():749429. PubMed ID: 34764870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
    Cottencin O; Rolland B; Karila L
    Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Akathisia after chronic usage of synthetic cathinones: A case study.
    Albert N; Catthoor K; Morrens M
    Front Psychiatry; 2022; 13():1046486. PubMed ID: 36620653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic cathinones and their phenethylamine analogues produce distinct psychomotor and reward behavior in crayfish.
    Gore S; van Staaden MJ; Sprague JE; Huber R
    Behav Brain Res; 2020 Feb; 379():112368. PubMed ID: 31743730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
    German CL; Fleckenstein AE; Hanson GR
    Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.